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mediating the pancreatic b-cell injury. Both the decreased viability and the dysfunction of b-cells
have become the key factors in the development of diabetes mellitus. Thus, it is of utmost
importance to elucidate the discrete pathological changes in pancreatic b-cells within the context of
the various lipotoxicity models. The goal of these studies is to generate evidence to improve not
only the clinical treatment for diabetics, but also modulate the diet and activities of groups at high
risk for diabetes. In this regard, we review the role of lipotoxicity in pancreatic b-cell injury and
identify potential therapeutic targets in this cell model.
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Glucose and fatty acids are the two main nutrients in energy
metabolism in most organisms, and are of particular interest in
metabolic diseases such as diabetes and obesity. Though the
speciﬁc pathogenesis of these metabolic diseases remains unclear,
considerable evidence showing the deleterious effects of elevated
glucose and fatty acid levels on pancreatic b-cell viability and
function has been generated in recent years. Moreover, several
hypotheses including glucotoxicity1 and lipotoxicity2 caused by
chronic hyperglycemia and chronic dyslipidemia, respectively,
have been well established. With prolonged exposure to these
harmful conditions, pancreatic b-cell function and viability
worsen over time, further impairing the metabolism of glucose
and lipids in a detrimental cycle leading to further b-cell damage
and, ultimately, diabetes.
Currently, a high fat diet has been considered as one of the
causative factors in the decline of b-cell survival and function.
The absorption of excess fatty acids can result in an elevated
free fatty acid (FFA) level in blood and is worthy of close
attention, as the extra FFAs that are not able to be appro-
priately metabolized can produce many negative effects via
multiple pathways in pancreatic b-cells and may lead to b-cell
apoptosis.Figure 1 Cellular and molecular basis of pancreatic b-cell
damage.2. Fatty acid metabolism and lipotoxicity
Fatty acids and glycerol are mainly generated from triacylgly-
cerol via catalysis by various lipases activated at the initial step
of fatty acid metabolism, which is recognized as fat mobiliza-
tion. Insulin and prostaglandin are able to inhibit fat mobi-
lization, reduce the generation of fatty acid, and prevent the
actions of many lipotropins such as adrenaline and glucagon,
which can activate adenylate cyclase via cell membrane surface
receptors and further stimulate the intracellular lipases via the
phosphorylation of PKA. Free fatty acids are subsequently
activated by long-chain fatty acid-CoA synthetase leading to
the formation of long-chain fatty acid-CoA. In contrast to
short-chain fatty acid-CoA (oC10), carnitine-acyl transferase
(CAT) is needed for long-chain fatty acid-CoA transport into
mitochondria. The activity of CAT-1, the rate-limiting enzyme
of long-chain fatty acid-CoA transport and metabolism, is
signiﬁcantly increased in some conditions such as diabetes and
chronic high fat or low sugar diet, indicating that CAT-1
could be recognized as a potential regulatory target in
disorders of lipid metabolism. Therefore, chronic fatty-acid
exposure could be deleterious through its various impacts on
the intracellular fatty-acid metabolism.
Accordingly, malonyl-CoA, a product of glucose metabo-
lism in the cytoplasm, possesses a beneﬁcial effect by inhibit-
ing CAT-1 activity3, thereby blocking the transport of long-
chain fatty acid-CoA into mitochondria. This would lead to
the accumulation of long-chain fatty acid-CoA, potentially
resulting in many deleterious effects on b-cell function and
viability. The rise in apoptosis in INS-1E cells was partially
reversed by the inclusion of the AMP-activated protein kinase
(AMPK) agonist AICAR4, which increased the oxidation of
palmitate; during culture in low glucose palmitate-triggered
apoptosis is accentuated both in human islets and b-cell lines
when the carnitine-palmitoyl transferas-1 (CPT-1) inhibitor
etomoxir was present. Etomoxir under these low glucoseconditions decreased palmitate oxidation. However, in work
by the group of Jun5, treatment with carnitine and with
carnitine-lipoic acid increased the mRNA levels of both
CPT-1 and peroxisome proliferator activated receptor-g
(PPAR-g), which controls lipid synthesis and storage in
adipose tissue6, in the presence of thiazolidinedione. Thus,
carnitine and carnitine-lipoic acid can prevent lipotoxicity by
increasing mitochondrial b-oxidation and reducing intracellu-
lar oxidative stress. Moreover, it has also been reported that
CPT-1 was upregulated by the GW501516-induced activation
of PPARd, which further attenuated apoptosis and reduced
basal insulin secretion induced by palmitate in HIT cells7. It
was also observed that stearate, but not oleate, inhibited cell
proliferation and induced cell death, and the activation of
stearate in the form of stearoyl-CoA was a necessary element
for the lipotoxic effects8. According to these data, it was
concluded that the interruption of triacylglycerol synthesis in
the endoplasmic reticulum, possibly because of the formation
of a pool of oversaturated intermediates, represents a key
event in the mechanism of saturated fatty acid-induced
lipotoxicity.3. Fatty acid metabolism and pancreatic b-cell damage
3.1. Ceramide formation
In recent years, research on cytokine-mediated cytotoxicity
has gained extensive attention. Accumulating evidence reveals
that the apoptosis of pancreatic b-cells has a direct relation-
ship with ceramide formation (Fig. 1). An elevated level of
ceramide has been found in the islets of Zucker Diabetic Fatty
(ZDF) rats and the b-cell apoptosis mediated by the enhanced
ceramide biosynthesis was effectively prevented by treatment
with fumonisin B1, a ceramide synthase inhibitor, in these
rats9. Moreover, C2-ceramide, an analog of ceramide which
can freely cross cell membranes, is able to potentiate the
effects of palmitate on pro-apoptosis and anti-proliferation in
b-cells10.
3.2. Endoplasmic reticulum (ER) stress
The detailed mechanism of generation of ER stress induced by
saturated fatty acids such as palmitate in b-cells mainly
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Notably, the activity of ER Ca2þ channels regulates the
susceptibility of b-cells to ER stress, and the involvement of
mitochondria in b-cell apoptosis associated with dysfunctional
b-cell ER Ca2þ homeostasis and ER stress is also suggested
in a second study12, suggesting that under the deleterious
conditions resulting from high nutritional intake various
kinds of pro-apoptotic pathways are activated following
ER stress in pancreatic b-cells. Furthermore, palmitate
reduced carboxypeptidase E (CPE) protein levels within 2 h,
prior to ER stress and cell death in MIN6 b-cells; and
conversely, overexpression of CPE could partially rescue
b-cells from palmitate-induced ER stress and apoptosis,
indicating that palmitate was able to induce the b-cell ER
stress and apoptosis via facilitating the degradation of CPE13.
Interestingly, the lack of proapoptotic thioredoxin-interacting
protein (TXNIP) speciﬁcally inhibits the mitochondrial death
pathway underlying b-cell glucotoxicity, whereas it has very
few protective effects against ER stress-mediated lipoapopto-
sis14. Additionally, it has been reported that reductions in
eukaryotic translation initiation factor 2a (elF2a) phosphor-
ylation, an adaptive response to ER stress, was able to trigger
the b-cell failure, whereas excessive elF2a phosphorylation
is poorly tolerated by human islets and exacerbates fatty
acid-induced apoptosis through ER and mitochondrial
mechanisms15.3.3. Oxidative stress and inﬂammation
Recently, intensive studies have disclosed that mitochondria
possess some precise connections with cell death16,17. It has been
reported that mitochondria are prone to dysfunction under high
nutritional conditions in both MIN6 and INS-1 cells, and
alterations in mitochondrial membrane permeability were also
detected in the early stage of b-cell apoptosis18. More speciﬁcally,
prolonged exposure to fatty acids would lead to the enhanced
biosynthesis of ROS generated by the mitochondria in b-cells; on
one hand, the elevated levels of ROS could increase the
permeability of cell membrane via oxidizing lipid components,
resulting in the calcium inﬂux and the activation of phospholi-
pase, which would further degrade cell membrane phospholipids
and induce b-cell apoptosis; on the other hand, ROS is able to
up-regulate the NF-kB protein levels, increase the NO free
radical production via augmenting iNOS activity, and ﬁnally
cause b-cell death19. The intracellular elevated levels of NF-kB
are also closely related to the inﬂammatory response in b-cells: as
introduced in Yuan’s study, the free fatty acid levels in obese
animal models were signiﬁcantly decreased after treatment with
aspirin; moreover, many pathological changes, such as hypergly-
cemia, hyperinsulinemia, and reduction in the number of b-cells,
were all markedly improved20. More recently, the detailed
molecular mechanisms of ROS-mediated lipotoxicity in insulin-
producing RINm5F cells and INS-1E cells as well as in primary
rat islet cells were analyzed. Only long-chain (4C14) saturated
nonesteriﬁed fatty acids (NEFAs) were toxic to insulin-produ-
cing cells. Notably, overexpression of catalase in peroxisomes
and in the cytosol, but not in mitochondria, signiﬁcantly reduced
H2O2 formation and protected the cells from palmitic acid-
induced toxicity, demonstrating that H2O2 formation in peroxi-
somes rather than in mitochondria is responsible for NEFA-
induced toxicity21,22.3.4. B cell lymphoma protein and caspase family
The role of B cell lymphoma (Bcl) and caspase proteins in the
fatty-acid mediated apoptosis of b-cells, which might also
contribute to the b-cell loss in type 2 diabetes, has been studied
by several research groups in recent years. In contrary to Bax
and Bcl-XL, Bcl-2 and Bal-2 normally exert an anti-apoptotic
action in b-cells. Under the stimulation of fatty acids, Bcl-2
mRNA levels were signiﬁcantly decreased in isolated human islet
cells, while the levels of Bax remained unchanged11, which
indicated that the b-cell anti-apoptotic ability could be impaired
by fatty-acid induced actions. In particular, caspase-3, a down-
stream molecule in the apoptotic signaling pathway, is a key
signaling enzyme mediating various kinds of cell death. Palmitate
was able to induce caspase-6 activity within 3 h and caspase-3
activity after a lag period of 6 h in mouse b-cells; moreover, a
caspase-6 inhibitor attenuated the caspase-3 activation and cell
death induced by palmitate, and in treatment with oxfenicine, an
inhibitor of CPT-1, both the palmitate-induced cytotoxicity and
the activation of caspase were attenuated in an in vitro study23,
suggesting that fatty acids could possess a pro-apoptotic effect in
pancreatic b-cells via caspase activation along with a possible
involvement of mitochondria-mediated pathways.3.5. Insulin signal pathway and PKB
Insulin is an important hormone that can efﬁciently facilitate the
biosynthesis of glycogen and triacylglycerol in organisms, and
the binding to its receptors in the cell membrane leads to a
persistent activation of phosphatidyl inositol 3-kinase (PI3K),
which could further activate protein kinase B (PKB). PKB is
expressed in b-cells in pancreatic islets, and its activation can
subsequently trigger a cascade response yielding b-cell prolifera-
tion and the inhibition of b-cell apoptosis. Notably, the over-
expression of insulin receptor substrate-2 (IRS-2) inhibited the
fatty-acid mediated apoptosis in INS-1 cells and enhanced PKB
activity causing reduced caspase-9 protein levels; moreover, a
threefold number of apoptotic b-cells was detected after IRS-2
was down-regulated, which was considered to be correlated with
the inhibition of PKB24. More speciﬁcally, the downstream
molecules involved in the PKB inhibition-induced apoptosis
have been recognized as glycogen synthase kinase-3 (GSK-3)
and forkhead transcription factor O1 (FoxO1), which were
inhibited after PKB activation, leading to protective effects on
b-cell viability. In addition, p53 protein levels were signiﬁcantly
down-regulated by PKB activation, which might also contribute
to its ability to protect b-cells from apoptosis25. More recently, it
has been reported that incubation of isolated islets from
carbohydrate-restricted New Zealand Obese (NZO) mice or
MIN6 cells with palmitate and glucose resulted in the depho-
sphorylation of FoxO1 and thymoma viral proto-oncogene 1
(Akt) without changing the levels of either protein26. Thus, in
response to hyperglycemia or hyperlipidemia, FoxO1 is depho-
sphorylated, leading to the reduced levels of b-cell-speciﬁc
transcription factors and to the apoptosis of b-cells. It has been
determined that N-myc downstream-regulated gene 2 (NDRG2),
which is involved in cell differentiation and apoptosis, localizes
mainly in the cytoplasm of pancreatic b-cells and its phosphor-
ylation was signiﬁcantly enhanced after overexpression of con-
stitutively activated Akt, which further abolished the apoptosis
induced by fatty acids in b TC3 cells, whereas NDRG2
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against fatty acid-triggered apoptosis27.
3.6. MicroRNA
Based on recent estimates, up to one third of all human genes
may be regulated by miRNAs, small noncoding RNA mole-
cules which have been suggested to play a central role in a
variety of physiological processes and human diseases. As
studied in MIN6 cells and isolated pancreatic islets28, an
involvement of miRNAs in palmitate-induced apoptosis had
been determined; particularly, a time- and dose-dependent
increase of miR34a and miR146 caused by prolonged expo-
sure to palmitate has been noted. The rise of miR34a was
linked to activation of p53 and resulted in sensitization to
apoptosis, while higher miR146 levels contributed to the
increased apoptosis in b-cells; notably, treatment with oligo-
nucleotides that block miR34a or miR146 activity partially
protected palmitate-treated cells from apoptosis28. Such data
strongly suggest that miRNAs are a potential group of
regulators for many complicated human diseases, including
diabetes and cancer, although there still remains much to be
learned on the various roles of microRNAs.Figure 2 Regulation of insulin secretion in pancreatic b-cells.4. Fatty acids and insulin biosynthesis deﬁciency
It has been extensively reported that prolonged exposure to
fatty acids could seriously impair insulin biosynthesis in the
presence of high glucose. The detailed mechanisms whereby
fatty acids impact insulin biosynthesis are possibly correlated
with the activities of transcription factors such as pancreas-
duodenum homeobox 1(PDX-1) and MafA. Palmitate may
play a role in affecting insulin gene expression via enhancing
ceramide formation, which further impairs the activities of
these transcription factors29. Additionally, JNK, one of the
target molecules of ceramide, can negatively regulate insulin
gene expression in transcriptional levels as well. Palmitate
represses insulin expression via activating JNK and the
phosphorylation of IRS at particular sites30. To ascertain
other mechanisms whereby palmitate inhibits insulin gene
expression in pancreatic b-cells, extracellular-regulated kinase
(ERK) 1/2 phosphorylation, PKB phosphorylation, and Per-
Arnt-Sim kinase (PASK) expression were examined in a recent
work31. The study revealed an increase of ERK 1/2 and PKB
phosphorylation in MIN6 cells, which was synergistically
enhanced by elevated glucose and palmitate levels. Inhibition
of ERK 1/2 partially prevented the reduction of insulin gene
expression in the presence of palmitate or ceramide. More-
over, overexpression of PASK increased insulin gene expres-
sion in MIN6 cells and rat islets incubated with palmitate.
Thus, these ﬁndings indicated that both the PASK and ERK
1/2 signaling pathways mediate the palmitate-induced inhibi-
tion of insulin gene expression. In addition, as reviewed by
Eizirik32, the endoplasmic reticulum would be rendered more
vulnerable to high glucose and fatty acid exposure, which
enhances insulin biosynthesis and insulin secretion at the early
stage, but lead to b-cell loss and insulin resistance in chronic
conditions. Accordingly, the activation of the ATF6 transcrip-
tion factor, a component of the unfolded protein response
(UPR) which negatively regulates insulin gene expression,
plays a dual role in b-cells, acting as a beneﬁcial regulatorpreventing b-cells from ER stress under physiological condi-
tions or as triggers of b-cell dysfunction and apoptosis under
chronic situations. Overall, the fatty acid-mediated regulations
of insulin gene expression by various pathways is of interest,
and the studies for the mechanisms by which fatty acids act
are still needed to offer a more comprehensive understanding
towards different regulations.5. Fatty acids and insulin secretion deﬁciency
5.1. Aquaporin (AQP)
For the last 20 years, accumulating evidence has shown that
glucose-stimulated insulin secretion (GSIS) is signiﬁcantly
repressed upon exposure to chronic fatty-acid stimulation.
To investigate the speciﬁc roles of fatty acids in regulating
pancreatic b-cell function, many proteins and signaling path-
ways relating to insulin secretion have been evaluated. Among
them, some aquaporin family members, known as the mam-
malian glycerol channels in pancreatic b-cells, are of consider-
able interest (Fig. 2). AQPs that transport both water and
glycerol or other small solutes are collectively known as
aquagly ceroporins, namely, AQP3, AQP7, AQP9, and
AQP10 (a pseudogene in murines). Interestingly, only the
expression of AQP7, and not that of AQP3 or AQP9, was
detected in the endocrine pancreas at both the mRNA
and protein levels according to one study33. Furthermore,
AQP7/ mice displayed increased islet TG content, reduced
b-cell mass and insulin content, but increased insulin mRNAs.
Concomitantly, there was a decreased rate of cell proliferation
in these AQP7/ mice. Hence, AQP7, the only expressed
glycerol channel in b-cells, appears to be a vital regulator of
intra-islet glycerol content as well as insulin production and
secretion, which also implies that AQP7 is the most likely
mediator involved in the generation of b-cell dysfunction
mediated by lipid metabolism. Other AQPs like AQP1, which
exclusively function as water channels, have also been
reported to play a key role in regulating insulin secretion.
Dense-core secretory granules (DCSGs) are a hallmark of
endocrine and secretory cells and are responsible for the
regulation of secretion of many hormones including insulin34.
In particular, AQP1 is present in dense-core secretory granule
membranes of pituitary and adrenal medulla cells. AQP1-
deﬁcient endocrine cells showed more than 60% depletion of
DCSGs and signiﬁcantly decreased DCSG protein levels35.
Notably, the presence of AQPs in intracellular organelles such
Haopeng Yang, Xuejun Li400as vesicles has also been demonstrated36. The secretory
granules and vesicles contain secretory proteins, and migrate
to particular locations close to the plasma membrane to
release their contents via the fusion of vesicle membrane and
cell membrane as well as via exocytosis events. During this
process the swelling of vesicles and the regulation of vesicle
volume is very important for exocytosis in the secretion of
hormones. Notably, AQP is believed to have considerable
impact on the trafﬁc of secretory vesicles, vesicle swelling and
exocytosis37,38. Therefore, impaired insulin secretion possibly
mediated by fatty acids involves many biological events and
regulators, and considering the disorder of a series of secretory
processes in endocrine cells, the detailed mechanisms might, at
least in part, lie at the level of the regulatory and other roles of
AQPs in response to the over-fuel stimuli. Hence, AQP, a
classic family of membrane channels, is emphasized here as a
potential curative target towards metabolic syndromes such as
diabetes and obesity as a result of its crucial role in mediating
the transport of water and glycerol as well as in regulating
insulin secretion in pancreatic b-cells.5.2. AMPK-related pathways and insulin secretion
While it is now generally accepted that AMPK is a key energy
sensor that regulates cellular catabolism as well as insulin
secretion, the effect of palmitate on the activity of AMPK in
b-cells was examined by the research group of Luo39. AMPK
activation and acetyl-CoA carboxylase (ACC) phosphoryla-
tion were detected in isolated rat islets and MIN6 cells treated
with palmitate, and the activation of AMPK by 24 h pretreat-
ment with palmitate suppressed GSIS in the same study.
Furthermore, accumulation of triglyceride (TG) subsequent
to the activation of ACC by suppression of AMPK activity
was suggested to be, at least in part, responsible for the
impaired insulin secretion40. Fatty-acid treatment could also
result in the overexpression of the transcription factor sterol
regulatory element-binding protein (SREBP)-1c, which is a
downstream molecule of AMPK, and the lipotoxic effects of
fatty acids were largely prevented by the induction of a
SREBP-1c small interfering RNA41. Palmitate was also found
to up-regulate the expression of SREBP-1c and down-regulate
the levels of transcription factor pancreas-duodenum homeo-
box 1 (Pdx-1) as well as glucagon-like peptide-1 receptor
(GLP-1R) in INS-1 cells42. These results suggested that the
SREBP-1c-Pdx-1-GLP-1R signal pathway was involved in
palmitate-induced GSIS impairment in b-cells. In addition,
granuphilin is also a crucial component of the docking
machinery that couples insulin-containing vesicles to the
plasma membrane43, and could be activated in several diabetic
mouse models and normal islets treated with palmitate,
accompanied by a corresponding reduction in insulin secre-
tion. Knockout-mediated ablation of granuphilin or SREBP-
1c restored potassium-stimulated insulin secretion in these
islets. It has also been proposed that glucose and fatty acids
reduce insulin secretion by interference with the exit of insulin
via the fusion pore44. Additionally, fatty acids binding proteins
(FABPs) are involved in the uptake, binding, transport and
metabolism of fatty acids as well, and both FABP3 and
FABP5 may play a role in insulin secretion. b-oxidation of
fatty acids is required for the gene expression of both FABP
genes in INS-1E cells. Inhibition of CPT-1 by etomoxirinhibited the oleic acid-induced FABP3 and FABP5 gene
expression, while activation of AMPK by metformin ampliﬁed
the oleic-induced expression of both FABPs45.
5.3. Protein kinase C (PKC)
According to the work by the research group of Peyot46, it was
suggested that endogenous b-cell lipid stores could provide the
exact signaling molecules for insulin release. The functional
ablation of PKCe has been shown to enhance GSIS in models
of type 2 diabetes47 recently. The group revealed an enhanced
rate of lipolysis in PKCe knock-out islets, and acute treatment
with lipase inhibitor blocked the enhancement of GSIS,
suggesting an interaction between PKCe and lipolysis and
further highlighting the therapeutic potential of PKCe inhibi-
tion to enhance GSIS from b-cells under conditions of lipid
excess. Consistently, it has also been reported that deletion of
PKCe augmented insulin secretion and prevented glucose
intolerance in fat-fed mice; and moreover, a PKCe-inhibitory
peptide improved insulin availability and glucose tolerance in
db/db mice with preexisting diabetes48. Being correlated with
the lipolysis in pancreatic b-cells, the hormone-sensitive lipase
(HSL)-mediated lipotoxicity could affect insulin secretion as
well and the deﬁciency of HSL exacerbated the accumulation
of TGs in ob/ob islets, leading to the reduced GSIS and
diminished islet mass49.
5.4. Uncoupling protein (UCP)
UCPs, mitochondrial inner membrane proteins, function as the
key mediators that can dissipate the proton gradient before it can
be used to provide energy for oxidative phosphorylation in
normal physiological status. More recently, UCP2 has been
shown to be associated with impaired pancreatic b-cell function
via the oxidative stress pathway. UCP2/ mice exhibited signi-
ﬁcantly increased oxidative stress. Interestingly, GSIS in UCP2/
islets was meaningfully decreased as well, indicating that the
absence of UCP2 causes oxidative stress in b-cells and is
accompanied by impaired GSIS50. Hence, according to the
viewpoint of Poitout51, the increase in UCP2 expression
observed in islets after high-fat feeding in rodents or in vitro
likely represents a cellular defense mechanism against fuel
overload rather than a deleterious response.
5.5. Nuclear receptor proteins
PPAR proteins are a group of nuclear receptor proteins that
essentially function as transcription factors regulating cellular
differentiation, metabolism and tumorigenesis. In particular,
PPARa has been proposed to play a protective role against the
unsaturated fatty acid-induced lipodysfunction in b-cells52. In
INS-1E cells, the secretory dysfunction primarily induced by
oleate was aggravated by silencing of PPARa; and conversely,
PPARa un-regulation preserved GSIS, which was also observed
in human islets. PPARa overproduction increased both
b-oxidation and fatty acid storage. Thus, PPARa is able to
protect b-cells from oleate-induced dysfunction, promoting both
glucose and fatty-acid metabolic pathways. Accumulating data
suggest that cholesterol homeostasis is also a major regulator of
b-cell function. Intracellular cholesterol accumulation leads to
impaired insulin secretion and impacts both the b-cell membrane
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of GSIS53; and it has also been proposed that essential
cholesterol modulators like ATP-binding cassette transporter
A1 (ABCA1) and LDL receptor are able to regulate insulin
secretion coherently54. Moreover, farnesoid X receptor (FXR),
also known as bile acid receptor (BAR), is another key nuclear
receptor protein in humans, and it has also been showed that
FXR is expressed in and functions in human islets and b-cell
lines. Interestingly, FXR predominantly localizes in cytosol in
the islets of lean mice, but in the nucleus in obese mice55.
According to the results of this study, GSIS was impaired in
islets of FXR/ mice, and FXR activation protected human
islets from lipotoxicity and ameliorated the secretory index.6. Summary
To sum up, though major progress has been made towards a
more complete picture of the cellular and molecular mechan-
isms of pancreatic b-cell lipotoxicity, speciﬁc correlations
between the detailed biological events and the development
of diabetes are not yet understood and additional investiga-
tions are still much-needed to resolve the precise pathogenesis
and identify therapeutic targets for type 2 diabetes in humans.
The main elements contributing to the difﬁculties in under-
standing b-cell lipotoxicity are two-fold. On one hand, due to
the complexities in developing a chronic over-nutrition study
model in vivo, many studies have selected the insulin-produ-
cing b-cell lines or isolated islets in vitro as the experimental
subjects. The research-based outcomes from these in vitro
systems are usually lacking in consistency or reliability. On the
other hand, both glucotoxicity and lipotoxicity refer to a
disorder mainly resulting from the chronic conditions, and it
remains very hard to accurately deﬁne or mimic the speciﬁc
process of diabetic development in regards to the chronic
conditions. To overcome these difﬁculties, novel research
methods and systems need to be established. Considering that
the precise molecules and pathways mediating the pancreatic
b-cell lipotoxicity are numerous, it is necessary to provide a
comprehensive analysis of the physiological and pathological
status in b-cells so as to provide scientiﬁc evidence and
support for healthy life practices as well as to discover novel
anti-diabetes drugs and therapeutic targets in the future.Acknowledgment
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